SIRT2 and cancer: By linking SIRT2 activity to CMA regulation, our study not only advances our understanding of autophagic pathways but also raises the possibility of targeting SIRT2-HSC70 interactions as a therapeutic strategy for diseases associated with CMA dysregulation, such as neurodegeneration, cancer, and aging [14,15].